Development of PEGylated Liposomes

    October 2011
    I. Craig Henderson
    Image of study
    TLDR PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.
    The document from 12 years ago detailed the development and clinical application of PEGylated liposomal doxorubicin (PLD) as a drug delivery system in cancer treatment. PLD was designed to improve drug efficacy and reduce toxicity by enhancing pharmacokinetics and tissue distribution. It was shown to evade the immune system and deliver drugs effectively to target tissues, such as tumors. PLD demonstrated increased drug accumulation in tumors and improved therapeutic outcomes compared to free drugs. The document reported on PLD's pharmacokinetics, with a plasma half-life of 45-55 hours and a clearance that remains consistent over 2-3 weeks post-injection. Clinically, PLD had a toxicity profile with less nausea, vomiting, alopecia, and neutropenia but more palmar-plantar erythrodysesthesia (PPE), mucositis, and infusion reactions. Cardiotoxicity was also reduced with PLD compared to conventional doxorubicin. Studies involving patients with ovarian cancer, breast cancer, and AIDS-related Kaposi's sarcoma showed PLD's efficacy and lower toxicity. In pivotal trials, PLD was effective in treating ovarian cancer with fewer adverse events and improved progression-free survival (PFS) and overall survival (OS) compared to other treatments. In breast cancer, PLD was as effective as anthracyclines with a different toxicity profile and was beneficial as maintenance therapy. PLD also showed promise in multiple myeloma and soft-tissue sarcomas, with varying response rates and less cardiotoxicity. The document concluded that while PLD has proven benefits in increasing drug potency and reducing toxicities like cardiotoxicity and alopecia, more clinical data are needed to confirm the effectiveness of certain doses, and the potential of immunoliposomes remains to be demonstrated in clinical trials.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 4 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Androgenic alopecia exclusively on the vertex of the scalp

      in Chat  6 upvotes 6 months ago
      A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hair loss is common among men.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 8 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Similar Research

    5 / 1000+ results